Reporte zur Charge EN6206 & EN0150

Symptomtext

Dizziness when stand up; Dizziness when move too fast; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 04Apr2021 at 10:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included aortic stenosis. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included valsartan (MANUFACTURER UNKNOWN) on an unknown date for unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6206) via an unspecified route of administration in the left arm on 13Mar2021 at 12:00 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. On 12Apr2021, the patient experienced dizziness when moved too fast or stood up. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events which included prescribed medications for dizziness. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event dizziness when stand up and dizziness when move too fast was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.